Massive Bio Collaborates with American Cancer Society to Expand Access to Cancer Clinical Trials Nationwide

Massive Bio is collaborating with the American Cancer Society to expand the ACS ACTS program, which helps patients navigate clinical trial options more easily. The program uses Massive Bio's AI-powered clinical trial matching technology to provide personalized options sourced from clinicaltrials.gov. The service is available to individuals of all ages with any cancer type across the US. Massive Bio aims to reduce barriers to care and increase diverse participation in clinical trials.